Hoy en "Diario AZprensa" puedes leer...

Showing posts with label ranking. Show all posts
Showing posts with label ranking. Show all posts

Saturday, April 12, 2025

The most dangerous places in the world to travel

International SOS, a company specializing in health and safety, has compiled a list of the most dangerous countries to visit, with Afghanistan topping the ranking. Following closely in terms of risk are Syria, Libya, the Central African Republic, and Iraq. However, as the report also points out, countries like Mali, Yemen, Somalia, Sudan, Nigeria, the Democratic Republic of the Congo, Pakistan, and Ukraine are nearly as hazardous.

On the opposite end of the spectrum, the safest countries for travelers are led by Norway, followed by Finland, Switzerland, Denmark, and Luxembourg.
 

A journey through the history of the pharmaceutical industry and one of its great laboratories that had its origins in Alfred Nobel...
“From Alfred Nobel to AstraZeneca” (Vicente Fisac, Amazon) is available in e-Book and print editions: https://a.co/d/9svRTuI

Monday, February 10, 2025

The largest Companies in the Global Pharmaceutical Industry

Analyzing which pharmaceutical companies had the highest sales in 2024 globally, we get the following picture:

Johnson & Johnson. - Leads the ranking with global sales reaching $85.16 billion. This company has remained strong thanks to the marketing of innovative drugs and high-quality products across various therapeutic areas.
 
Roche. - One of the leaders with significant profits, although the exact figures have not yet been detailed. However, their investment in research and development in 2024 was approximately $10 billion.
 
Pfizer. - Holds a prominent position with sales of $58.5 billion. Despite challenges like competition in the generics market, Pfizer continues to be a leader in the development of innovative treatments.
 
AbbVie. - Ranks fourth with earnings of $54.3 billion. Its focus on medications for chronic diseases and the marketing of innovative products has maintained its position in this ranking.
 
Novartis. - Detailed figures for 2024 are not yet available, but its consistent presence in the pharmaceutical market suggests it remains a significant competitor. It is known for its Innovative Medicines division and Sandoz division, which drive its revenues.
 
It's also worth noting that the market capitalization of these companies does not always directly reflect their annual sales, but it provides an idea of their value and market position. For example, Eli Lilly led in market capitalization with approximately $738.8 billion in March 2024, indicating its strong market presence.
 

An enthralling story of love, friendship and honor in the Olympic Games (2,600 years ago)
“Life debt” (Vicente Fisac, Amazon): https://a.co/d/hono34C